Outsourcing in Clinical Trials West Coast
- This event has passed.
Outsourcing in Clinical Trials West Coast
03/01/23 - 03/02/23
Arena International are delighted to announce Outsourcing in Clinical Trials West Coast will be returning to Burlingame for the annual event on March 1st & 2nd 2023!
For the 15th Annual event, our flagship show will focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed.
The 2023 program boasts 4 streams jam-packed with the latest content;
- Clinical Operations & Outsourcing
- Technology & Innovation
- Patient Engagement & Rare Diseases
- Medical Devices
Day 1 will kick off with a talk on designing a playbook for how to handle an undesirable CRO-Sponsor partnership, followed by a Keynote Panel allowing attendees to debate how to optimize their oversight & governance, led by Abby Kennedy (VP of Clinical Operations, CymaBay Therapeutics). Dan Solis from The FDA will give the closing keynote.
Genentech will give a case study session on piloting health inequities and gender identity data – why collecting this data now will aide you with your clinical trial.
The Patient Engagement track will be chaired by Estela Mata-Carcamo (Healthcare Advocate) and will delve into topics such as, outreach to minority groups, social determinants of health, and best practices for engaging the patient community. The Technology track will see Kimberley Ferguson (Commercial Head of Personalized Healthcare Partnerships, Genentech) discussing all things Wearables.
The 2023 program is filled with practical sessions, workshops and fireside chats, including one on overcoming barriers to trial innovation delivered by Dr Chris Apfel (CEO of SageMedic).
The Speaking Faculty includes; The FDA, Genentech, Roche, Iovance Biotherapeutics, Ascendis Pharma, FibroGen, Deciphera Pharmaceuticals, Union Therapeutics, Cymabay Therapeutics, RAPT Therapeutics and many more.